An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Transphorm Receives $16 Million from Existing Investors’ Exercise of Green Shoe
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Transphorm, Inc. (NASDAQ: TGAN) announced a significant financial boost, securing $16 million from the exercise of a green shoe option linked to a November 2021 private placement. This increases total equity financing proceeds to approximately $61 million since October 2021. As of June 3, 2022, the company's cash and equivalents exceed $45 million. CFO Cameron McAulay highlighted that this capital enhances operational flexibility to support future growth.
Positive
Total proceeds from equity financings since October 2021 reached approximately $61 million.
Cash and equivalents increased to over $45 million as of June 3, 2022.
Negative
None.
- Increases Cash and Equivalents as of June 3, 2022 to More than $45 Million -
GOLETA, Calif.--(BUSINESS WIRE)--
Transphorm, Inc. (Nasdaq: TGAN)—an innovative design pioneer and global supplier of efficient, high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today that it has received gross proceeds of $16 million as a result of the exercise of the green shoe associated with the Company’s private placement completed in November 2021.
The exercise brings the total proceeds from equity financings since October 2021 to approximately $61 million, before deducting offering expenses. As a result of the exercise, the Company has cash and cash equivalents of more than $45 million as of June 3, 2022.
Under the terms of the green shoe exercise, the Company issued 3,199,999 shares of its common stock as well as warrants to purchase an aggregate of 666,668 shares of its common stock at an exercise price of $6.00 per share.
Cameron McAulay, CFO of Transphorm, stated, “Over the past three quarters we have completed multiple equity financings from a combination of strategic and institutional investors, resulting in a significant increase in both the Company’s cash position and stockholders’ equity. This additional capital provides expanded operational flexibility in support of our current and anticipated future growth.”
The securities sold in the private placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state or other jurisdiction’s securities laws, and may not be resold absent registration under, or exemption from registration under, the Securities Act. Transphorm has agreed to file a registration statement with the Securities and Exchange Commission within 30 days of the closing registering the resale of the shares of common stock (and the shares of common stock issuable upon exercise of the warrants) issued to the investors in the private placement.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About Transphorm Transphorm, Inc., a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over 99% efficiency, 40% more power density and 20% lower system cost. Transphorm is headquartered in Goleta, California and has manufacturing operations in Goleta and Aizu, Japan. For more information, visit www.transphormusa.com and follow us on LinkedIn, Twitter @transphormusa and WeChat @Transphorm_GaN.
Forward-Looking Statements
This press release contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning the Company’s future anticipated growth. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: risks related to Transphorm’s operations, such as additional financing requirements and access to capital; competition; the ability of Transphorm to protect its intellectual property rights; and other risks set forth in the Company’s filings with the Securities and Exchange Commission. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
What is the latest financial update from Transphorm, Inc. (TGAN)?
Transphorm, Inc. announced that it has received $16 million from a green shoe exercise, bringing total equity financing since October 2021 to approximately $61 million and cash equivalents to over $45 million as of June 3, 2022.
What is the significance of the green shoe exercise for TGAN?
The green shoe exercise allowed Transphorm, Inc. to raise $16 million, enhancing its cash reserves and providing operational flexibility for future growth.
How much cash does Transphorm, Inc. (TGAN) have as of June 3, 2022?
As of June 3, 2022, Transphorm, Inc. has over $45 million in cash and cash equivalents.
What were the total proceeds from equity financings for TGAN since October 2021?
Transphorm, Inc. reported total proceeds from equity financings of approximately $61 million since October 2021.
